Microneedle array design determines the induction of protective memory CD8 + T cell responses induced by a recombinant live malaria vaccine in mice

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Carey, John B ^a   Pearson, Frances E ^b   Vrdoljak, Anto ^a   McGrath, Marie G ^a   Crean, Abina M ^a   Patrick, T ^a   Walsh, Patrick T ^c   Doody, Timothy ^a   O'Mahony, Conor ^d   Hill, Adrian V S ^b   Moore, Anne C ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^d UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

MALARIA ANTIGEN; MALARIA VACCINE; PARASITE ANTIGEN; RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA VACCINE; UNCLASSIFIED DRUG; LIVE VACCINE; RECOMBINANT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; MEMORY T LYMPHOCYTE; MICRONEEDLE ARRAY DESIGN; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PROTECTION; SPOROZOITE; ANIMAL; IMMUNOLOGY; INSTRUMENTATION; INTRADERMAL DRUG ADMINISTRATION; MALARIA; NEEDLE; PARASITOLOGY; PHENOTYPE; VACCINATION;

MUS; VACCINIA VIRUS ANKARA;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; INJECTIONS, INTRADERMAL; MALARIA; MALARIA VACCINES; MICE; NEEDLES; PHENOTYPE; SPOROZOITES; VACCINATION; VACCINES, ATTENUATED; VACCINES, SYNTHETIC;

EID: 79960719995     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022442     Document Type: Article

References (36)

1. Wolfson LJ, Gasse F, Lee-Martin SP, Lydon P, Magan A, et al. (2008) Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015. Bull World Health Organ 86: 27-39.
2. Nicolas JF, Guy B, (2008) Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 7: 1201-1214.
3. Ormerod LP, Garnett JM, (1988) Tuberculin response after neonatal BCG vaccination. Arch Dis Child 63: 1491-1492.
4. Ormerod LP, Palmer C, (1993) Tuberculin reactivity after neonatal percutaneous BCG immunisation. Arch Dis Child 69: 155.
5. Liu L, Zhong Q, Tian T, Dubin K, Athale SK, et al. (2009) Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity. Nat Med 16: 224-227.
6. Laurent PE, Bourhy H, Fantino M, Alchas P, Mikszta JA, (2010) Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults. Vaccine 28: 5850-5856.
7. Haq MI, Smith E, John DN, Kalavala M, Edwards C, et al. (2008) Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices 11: 35-47.
8. Wilke N, Mulcahy A, Ye SR, Morrissey A, (2005) Process optimization and characterization of silicon microneedles fabricated by wet etch technology. Microelectronics Journal 36: 650-656.
9. Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK, (2009) Microneedle-based vaccines. Curr Top Microbiol Immunol 333: 369-393.
10. Widera G, Johnson J, Kim L, Libiran L, Nyam K, et al. (2006) Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine 24: 1653-1664.
11. Draper SJ, Heeney JL, (2010) Viruses as vaccine vectors for infectious diseases and cancer. Nat Rev Microbiol 8: 62-73.
12. Hiraishi Y, Nandakumar S, Choi SO, Lee JW, Kim YC, et al. (2011) Bacillus Calmette-Guerin vaccination using a microneedle patch. Vaccine.
13. Dean CH, Alarcon JB, Waterston AM, Draper K, Early R, et al. (2005) Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum Vaccin 1: 106-111.
14. Moore AC, Gallimore A, Draper SJ, Watkins KR, Gilbert SC, et al. (2005) Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance. J Immunol 175: 7264-7273.
15. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 13: 843-850.
16. Bachmann MF, Wolint P, Schwarz K, Jager P, Oxenius A, (2005) Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L. J Immunol 175: 4686-4696.
17. Reyes-Sandoval A, Sridhar S, Berthoud T, Moore AC, Harty JT, et al. (2008) Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei. Eur J Immunol 38: 732-741.
18. Pham NL, Badovinac VP, Harty JT, (2009) A default pathway of memory CD8 T cell differentiation after dendritic cell immunization is deflected by encounter with inflammatory cytokines during antigen-driven proliferation. J Immunol 183: 2337-2348.
19. Joshi NS, Cui W, Chandele A, Lee HK, Urso DR, et al. (2007) Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281-295.
20. Vogt A, Mahe B, Costagliola D, Bonduelle O, Hadam S, et al. (2008) Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans. J Immunol 180: 1482-1489.
21. Milewski M, Brogden NK, Stinchcomb AL, (2010) Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin. Expert Opin Drug Deliv 7: 617-629.
22. Enfield J, O'Connell ML, Lawlor K, Jonathon E, O'Mahony C, et al. (2010) In vivo dynamic characterization of microneedle skin penetration using optical coherence tomography (OCT). J Biomedical Optics 15: 046001.
23. Kupper TS, (1990) The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol 94: 146S-150S.
24. Gopee NV, Roberts DW, Webb P, Cozart CR, Siitonen PH, et al. (2007) Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol Sci 98: 249-257.
25. Puri N, Weyand EH, Abdel-Rahman SM, Sinko PJ, (2000) An investigation of the intradermal route as an effective means of immunization for microparticulate vaccine delivery systems. Vaccine 18: 2600-2612.
26. Harvey AJ, Kaestner SA, Sutter DE, Harvey NG, Mikszta JA, et al. (2010) Microneedle-Based Intradermal Delivery Enables Rapid Lymphatic Uptake and Distribution of Protein Drugs. Pharm Res.
27. Badovinac VP, Messingham KA, Jabbari A, Haring JS, Harty JT, (2005) Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination. Nat Med 11: 748-756.
28. Finn JD, Bassett J, Millar JB, Grinshtein N, Yang TC, et al. (2009) Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus. J Virol 83: 12027-12036.
29. Tatsis N, Fitzgerald JC, Reyes-Sandoval A, Harris-McCoy KC, Hensley SE, et al. (2007) Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood 110: 1916-1923.
30. Koutsonanos DG, del Pilar Martin M, Zarnitsyn VG, Sullivan SP, Compans RW, et al. (2009) Transdermal influenza immunization with vaccine-coated microneedle arrays. PLoS One 4: e4773.
31. Good MF, Doolan DL, (1999) Immune effector mechanisms in malaria. Curr Opin Immunol 11: 412-419.
32. Schneider J, Gilbert SC, Blanchard TJ, Hanke T, Robson KJ, et al. (1998) Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med 4: 397-402.
33. Sridhar S, Reyes-Sandoval A, Draper SJ, Moore AC, Gilbert SC, et al. (2008) Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A. J Virol 82: 3822-3833.
34. Jabbari A, Harty JT, (2006) Simultaneous assessment of antigen-stimulated cytokine production and memory subset composition of memory CD8 T cells. J Immunol Methods 313: 161-168.
35. Draper SJ, Moore AC, Goodman AL, Long CA, Holder AA, et al. (2008) Effective induction of high-titer antibodies by viral vector vaccines. Nat Med 14: 819-821.
36. Belkaid Y, Jouin H, Milon G, (1996) A method to recover, enumerate and identify lymphomyeloid cells present in an inflammatory dermal site: a study in laboratory mice. J Immunol Methods 199: 5-25.